Company Filing History:
Years Active: 2013
Title: MariJean Eggen: Innovator in AKT Inhibitors
Introduction
MariJean Eggen is a prominent inventor based in Brownsburg, IN (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of AKT inhibitors. Her work has the potential to impact various therapeutic areas, showcasing her innovative spirit and dedication to advancing medical science.
Latest Patents
MariJean Eggen holds a patent for AKT inhibitors, which are described by the formula: Formula I. The present invention provides pharmaceutical compositions comprising compounds of Formula I, as well as the uses and methods of using these compounds. This patent highlights her expertise in creating effective pharmaceutical solutions.
Career Highlights
MariJean is currently employed at Eli Lilly and Company, a leading global pharmaceutical company. Her role at Eli Lilly allows her to collaborate with other talented professionals in the industry, further enhancing her contributions to innovative drug development.
Collaborations
Throughout her career, MariJean has worked alongside notable colleagues such as Douglas Wade Beight and Timothy Paul Burkholder. These collaborations have fostered a creative environment that encourages the exchange of ideas and expertise.
Conclusion
MariJean Eggen's work in the field of AKT inhibitors exemplifies her commitment to innovation in pharmaceuticals. Her contributions not only advance scientific knowledge but also hold promise for future medical applications.